Kazia Therapeutics Limited - ADR
KZIA
Get informed when a big investor buys or sells
+ FollowMarket Cap$21.96M
Close$
$2.48
81.6% downside
Current Fair Value
81.6% downsideOvervalued by 81.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $21.96 Million |
|---|---|
| Enterprise Value | $-47,327,998.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-18.9 |
| Beta | 2.15 |
| Outstanding Shares | 3,120,426 |
Return
| Return on Equity | -97.92% |
|---|---|
| Return on Assets | -63.98% |
| Return on Invested Capital | -90.83% |
Valuation & Multiples
| P/E Ratio | -1.88 |
|---|---|
| PEG | -1.39 |
| Price to Sales | - |
| Price to Book Ratio | 0.96 |
| Enterprise Value to Revenue | -18.84 |
| Enterprise Value to EBIT | 1.12 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
March 16, 2026
EPS Estimate
$-0.01
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
September 4, 2026
EPS Estimate
$-0.70
Average shareholder expectationRevenue Estimate
$139,923
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 56.21%▼ 23.25% |
|---|---|
| Total Invested | $13.05M▼ 23.57% |
| Investors Holding | 23▲ 1.00% |
ESG Score
No data